News | February 20, 2021
Unichem Laboratories receives ANDA approval for Apremilast Tablets
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis .
Apremilast tablets are indicated for the treatment of adult patients with moderate to severe plaque psoriasis .
Droxidopa Capsules, 100 mg, 200 mg, and 300 mg, are indicated for the treatment of orthostatic dizziness
posaconazole delayed-release tablets 100 mg are the generic equivalent of Noxafil.
Tavaborole Topical Solution, 5%, is an oxaborole antifungal.
Subscribe To Our Newsletter & Stay Updated
